J. Barber

发表

A phase II trial of continuous 5-fluorouracil in recurrent or metastatic transitional cell carcinoma of the urinary tract.

M. Parmar, R. Huddart, M. Highley, 2009, Clinical oncology (Royal College of Radiologists (Great Britain)).

Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array

J. R. Wilson, David M. Holden, P. W. Foster, 2016, British Journal of Cancer.

Bladder preservation in small cell carcinoma of the urinary bladder: an institutional experience and review of the literature.

J. Lester, E. Hudson, J. Barber, 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

SUCCINCT: An Open-label, Single-arm, Non-randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-line Treatment for Patients with Advanced Urothelial Carcinoma

R. Huddart, Robert J. Jones, S. Crabb, 2015, European urology.

A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma

T. Powles, S. Sundar, S. Brock, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

M. Parmar, M. Sydes, R. Cowan, 2011, The Lancet.

Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial.

M. Parmar, M. Sydes, D. Dearnaley, 2016, JAMA oncology.

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial

M. Parmar, M. Sydes, D. Dearnaley, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized, double blind, biomarker selected, phase II clinical trial of maintenance PARP inhibition following chemotherapy for metastatic urothelial carcinoma (mUC): Final analysis of the ATLANTIS rucaparib arm.

T. Powles, S. Sundar, S. Brock, 2022, Journal of Clinical Oncology.

Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial.

E. Frangou, M. Stockler, M. Parmar, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TGF‐β1 levels in pre‐treatment plasma identify breast cancer patients at risk of developing post‐radiotherapy fibrosis

S. Kumar, Shant Kumar, Chenggang Li, 1999, International journal of cancer.

Population‐based analysis of prostate‐specific antigen (PSA) screening in younger men (<55 years) in Australia

N. Lawrentschuk, D. Bolton, R. Persad, 2014, BJU international.

Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001)

L. Pickering, C. Cruickshank, E. Hall, 2013, British Journal of Cancer.

High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice.

M. Mason, J. Staffurth, N. Palaniappan, 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

Final analysis of intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therapy (RT) in locally advanced prostate cancer (CaP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110).

Bingshu E. Chen, M. Parmar, M. Sydes, 2012 .

Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: Preplanned interim results for the AVAST-M trial.

M. Gore, P. Nathan, P. Lorigan, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

M. Parmar, M. Sydes, R. Cowan, 2011, Lancet.

Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients

A. Hajeer, C. West, Shant Kumar, 2003, International journal of radiation biology.

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

M. Parmar, M. Sydes, R. Cowan, 2011, Lancet.